218 related articles for article (PubMed ID: 19654196)
1. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model.
Lynch HT; Lynch JF; Attard TA
CMAJ; 2009 Sep; 181(5):273-80. PubMed ID: 19654196
[No Abstract] [Full Text] [Related]
2. [Selection criteria for search for germ mutations in colorectal cancer hereditary nonpolyposis].
Ríos A; Rodríguez JM; Carbonel P; Parrilla P
Med Clin (Barc); 2015 Feb; 144(4):185-6. PubMed ID: 25458510
[No Abstract] [Full Text] [Related]
3. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
Jansen M; Menko FH; Brosens LA; Giardiello FM; Offerhaus GJ
Gastrointest Endosc; 2014 Dec; 80(6):1145-55. PubMed ID: 25434663
[No Abstract] [Full Text] [Related]
4. Identifying hereditary nonpolyposis colorectal cancer.
Lynch HT; Smyrk TC
N Engl J Med; 1998 May; 338(21):1537-8. PubMed ID: 9593794
[No Abstract] [Full Text] [Related]
5. Evaluation and management of Lynch syndrome.
Boland CR
Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
[No Abstract] [Full Text] [Related]
6. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer.
Vasen HF; Wijnen J
Cytogenet Cell Genet; 1999; 86(2):136-9. PubMed ID: 10545704
[No Abstract] [Full Text] [Related]
7. Diagnosis and management of hereditary non-polyposis colon cancer.
DeFrancisco J; Grady WM
Gastrointest Endosc; 2003 Sep; 58(3):390-408. PubMed ID: 14528214
[No Abstract] [Full Text] [Related]
8. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Lynch-like from Lynch syndrome.
Carethers JM
Gastroenterology; 2014 Mar; 146(3):602-4. PubMed ID: 24468183
[No Abstract] [Full Text] [Related]
10. More than just skin deep!: a report on a family with Muir-Torre syndrome.
Jairam N; Shivaram HV; Murthy RA; Yadav N; Sathish N; Kumar V A; Payal K; Pandey V
Int J Colorectal Dis; 2007 Aug; 22(8):987-9. PubMed ID: 16575605
[No Abstract] [Full Text] [Related]
11. HNPCC: an uncommon but important diagnosis.
Terdiman JP
Gastroenterology; 2001 Oct; 121(4):1005-8. PubMed ID: 11606514
[No Abstract] [Full Text] [Related]
12. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
[TBL] [Abstract][Full Text] [Related]
13. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?].
Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G
Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714
[TBL] [Abstract][Full Text] [Related]
14. Molecular screening for Lynch syndrome: from bench to bedside.
Jensen LH; Lindebjerg J; Kølvraa S; Crüger DG
J Clin Oncol; 2009 Dec; 27(34):e224; author reply e225. PubMed ID: 19858372
[No Abstract] [Full Text] [Related]
15. Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.
South SA; Hutton M; Farrell C; Mhawech-Fauceglia P; Rodabaugh KJ
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):543-5. PubMed ID: 17666659
[TBL] [Abstract][Full Text] [Related]
16. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
[TBL] [Abstract][Full Text] [Related]
17. HMLH1 and HMSH2 germline mutations in Greek families with hereditary non-polyposis colorectal cancer.
Kataki A; Gomatos IP; Arapis K; Mparatsis S; Alepas P; Kaintatzis A; Nikolopoulou M; Leandros E; Konstadoulakis MM; Bramis J
Clin Genet; 2006 Mar; 69(3):290-3. PubMed ID: 16542397
[No Abstract] [Full Text] [Related]
18. Identifying Lynch syndrome.
de la Chapelle A; Palomaki G; Hampel H
Int J Cancer; 2009 Sep; 125(6):1492-3. PubMed ID: 19536819
[No Abstract] [Full Text] [Related]
19. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation in breast and colorectal cancers.
Samowitz WS; Ogino S
Mod Pathol; 2008 Aug; 21(8):1054; author reply 1054-5. PubMed ID: 18654590
[No Abstract] [Full Text] [Related]
[Next] [New Search]
